三维酰胺质子转移加权成像可用于诊断早期乳腺癌:一项前瞻性单中心研究

IF 3.7 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Yeqin Li, Yan Zhang, Liwen Tian, Ju Li, Huihua Li, Ximing Wang, Cuiyan Wang
{"title":"三维酰胺质子转移加权成像可用于诊断早期乳腺癌:一项前瞻性单中心研究","authors":"Yeqin Li, Yan Zhang, Liwen Tian, Ju Li, Huihua Li, Ximing Wang, Cuiyan Wang","doi":"10.1186/s41747-024-00439-z","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>We investigated the value of three-dimensional amide proton transfer-weighted imaging (3D-APTWI) in the diagnosis of early-stage breast cancer (BC) and its correlation with the immunohistochemical characteristics of malignant lesions.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Seventy-eight women underwent APTWI and dynamic contrast-enhanced (DCE)-MRI. Pathological results were categorized as either benign (<i>n</i> = 43) or malignant (<i>n</i> = 37) lesions. The parameters of APTWI and DCE-MRI were compared between the benign and malignant groups. The diagnostic value of 3D-APTWI was evaluated using the area under the receiver operating characteristic curve (ROC-AUC) to establish a diagnostic threshold. Pearson’s correlation was used to analyze the correlation between the magnetization transfer asymmetry (MTR<sub>asym</sub>) and immunohistochemical characteristics.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The MTR<sub>asym</sub> and time-to-peak of malignancies were significantly lower than those of benign lesions (all <i>p</i> &lt; 0.010). The volume transfer constant, rate constant, and wash-in and wash-out rates of malignancies were all significantly greater than those of benign lesions (all <i>p</i> &lt; 0.010). ROC-AUCs of 3D-APTWI, DCE-MRI, and 3D-APTWI+DCE to differential diagnosis between early-stage BC and benign lesions were 0.816, 0.745, and 0.858, respectively. Only the difference between AUC<sub>APT+DCE</sub> and AUC<sub>DCE</sub> was significant (<i>p</i> &lt; 0.010). When a threshold of MTR<sub>asym</sub> for malignancy for 2.42%, the sensitivity and specificity of 3D-APTWI for BC diagnosis were 86.5% and 67.6%, respectively; MTR<sub>asym</sub> was modestly positively correlated with pathological grade (<i>r</i> = 0.476, <i>p</i> = 0.003) and Ki-67 (<i>r</i> = 0.419, <i>p</i> = 0.020).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>3D-APTWI may be used as a supplementary method for patients with contraindications of DCE-MRI. MTR<sub>asym</sub> can imply the proliferation activities of early-stage BC.</p><h3 data-test=\"abstract-sub-heading\">Relevance statement</h3><p>3D-APTWI can be an alternative diagnostic method for patients with early-stage BC who are not suitable for contrast injection.</p><h3 data-test=\"abstract-sub-heading\">Key points</h3><p>• 3D-APTWI reflects the changes in the microenvironment of early-stage breast cancer.</p><p>• Combined 3D-APTWI is superior to DCE-MRI alone for early-stage breast cancer diagnosis.</p><p>• 3D-APTWI improves the diagnostic accuracy of early-stage breast cancer.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>\n","PeriodicalId":36926,"journal":{"name":"European Radiology Experimental","volume":"268 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"3D amide proton transfer-weighted imaging may be useful for diagnosing early-stage breast cancer: a prospective monocentric study\",\"authors\":\"Yeqin Li, Yan Zhang, Liwen Tian, Ju Li, Huihua Li, Ximing Wang, Cuiyan Wang\",\"doi\":\"10.1186/s41747-024-00439-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Background</h3><p>We investigated the value of three-dimensional amide proton transfer-weighted imaging (3D-APTWI) in the diagnosis of early-stage breast cancer (BC) and its correlation with the immunohistochemical characteristics of malignant lesions.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>Seventy-eight women underwent APTWI and dynamic contrast-enhanced (DCE)-MRI. Pathological results were categorized as either benign (<i>n</i> = 43) or malignant (<i>n</i> = 37) lesions. The parameters of APTWI and DCE-MRI were compared between the benign and malignant groups. The diagnostic value of 3D-APTWI was evaluated using the area under the receiver operating characteristic curve (ROC-AUC) to establish a diagnostic threshold. Pearson’s correlation was used to analyze the correlation between the magnetization transfer asymmetry (MTR<sub>asym</sub>) and immunohistochemical characteristics.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>The MTR<sub>asym</sub> and time-to-peak of malignancies were significantly lower than those of benign lesions (all <i>p</i> &lt; 0.010). The volume transfer constant, rate constant, and wash-in and wash-out rates of malignancies were all significantly greater than those of benign lesions (all <i>p</i> &lt; 0.010). ROC-AUCs of 3D-APTWI, DCE-MRI, and 3D-APTWI+DCE to differential diagnosis between early-stage BC and benign lesions were 0.816, 0.745, and 0.858, respectively. Only the difference between AUC<sub>APT+DCE</sub> and AUC<sub>DCE</sub> was significant (<i>p</i> &lt; 0.010). When a threshold of MTR<sub>asym</sub> for malignancy for 2.42%, the sensitivity and specificity of 3D-APTWI for BC diagnosis were 86.5% and 67.6%, respectively; MTR<sub>asym</sub> was modestly positively correlated with pathological grade (<i>r</i> = 0.476, <i>p</i> = 0.003) and Ki-67 (<i>r</i> = 0.419, <i>p</i> = 0.020).</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusions</h3><p>3D-APTWI may be used as a supplementary method for patients with contraindications of DCE-MRI. MTR<sub>asym</sub> can imply the proliferation activities of early-stage BC.</p><h3 data-test=\\\"abstract-sub-heading\\\">Relevance statement</h3><p>3D-APTWI can be an alternative diagnostic method for patients with early-stage BC who are not suitable for contrast injection.</p><h3 data-test=\\\"abstract-sub-heading\\\">Key points</h3><p>• 3D-APTWI reflects the changes in the microenvironment of early-stage breast cancer.</p><p>• Combined 3D-APTWI is superior to DCE-MRI alone for early-stage breast cancer diagnosis.</p><p>• 3D-APTWI improves the diagnostic accuracy of early-stage breast cancer.</p><h3 data-test=\\\"abstract-sub-heading\\\">Graphical Abstract</h3>\\n\",\"PeriodicalId\":36926,\"journal\":{\"name\":\"European Radiology Experimental\",\"volume\":\"268 1\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Radiology Experimental\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41747-024-00439-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Radiology Experimental","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41747-024-00439-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

背景我们研究了三维酰胺质子转移加权成像(3D-APTWI)在早期乳腺癌(BC)诊断中的价值及其与恶性病变免疫组化特征的相关性。病理结果分为良性病变(43 例)和恶性病变(37 例)。良性组和恶性组的 APTWI 和 DCE-MRI 参数进行了比较。使用接收者操作特征曲线下面积(ROC-AUC)评估 3D-APTWI 的诊断价值,以确定诊断阈值。结果恶性肿瘤的磁化转移不对称性(MTRasym)和峰值时间显著低于良性病变(均为 p <0.010)。恶性肿瘤的体积转移常数、速率常数、洗入率和洗出率均明显高于良性病变(均 p < 0.010)。3D-APTWI、DCE-MRI 和 3D-APTWI+DCE 鉴别诊断早期 BC 和良性病变的 ROC-AUC 分别为 0.816、0.745 和 0.858。只有 AUCAPT+DCE 和 AUCDCE 之间的差异具有显著性(p < 0.010)。当 MTRasym 的恶性阈值为 2.42% 时,3D-APTWI 对 BC 诊断的敏感性和特异性分别为 86.5% 和 67.6%;MTRasym 与病理分级(r = 0.476,p = 0.003)和 Ki-67 (r = 0.419,p = 0.020)呈轻度正相关。相关性声明3D-APTWI可作为不适合注射造影剂的早期乳腺癌患者的替代诊断方法。关键点-3D-APTWI反映了早期乳腺癌微环境的变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

3D amide proton transfer-weighted imaging may be useful for diagnosing early-stage breast cancer: a prospective monocentric study

3D amide proton transfer-weighted imaging may be useful for diagnosing early-stage breast cancer: a prospective monocentric study

Background

We investigated the value of three-dimensional amide proton transfer-weighted imaging (3D-APTWI) in the diagnosis of early-stage breast cancer (BC) and its correlation with the immunohistochemical characteristics of malignant lesions.

Methods

Seventy-eight women underwent APTWI and dynamic contrast-enhanced (DCE)-MRI. Pathological results were categorized as either benign (n = 43) or malignant (n = 37) lesions. The parameters of APTWI and DCE-MRI were compared between the benign and malignant groups. The diagnostic value of 3D-APTWI was evaluated using the area under the receiver operating characteristic curve (ROC-AUC) to establish a diagnostic threshold. Pearson’s correlation was used to analyze the correlation between the magnetization transfer asymmetry (MTRasym) and immunohistochemical characteristics.

Results

The MTRasym and time-to-peak of malignancies were significantly lower than those of benign lesions (all p < 0.010). The volume transfer constant, rate constant, and wash-in and wash-out rates of malignancies were all significantly greater than those of benign lesions (all p < 0.010). ROC-AUCs of 3D-APTWI, DCE-MRI, and 3D-APTWI+DCE to differential diagnosis between early-stage BC and benign lesions were 0.816, 0.745, and 0.858, respectively. Only the difference between AUCAPT+DCE and AUCDCE was significant (p < 0.010). When a threshold of MTRasym for malignancy for 2.42%, the sensitivity and specificity of 3D-APTWI for BC diagnosis were 86.5% and 67.6%, respectively; MTRasym was modestly positively correlated with pathological grade (r = 0.476, p = 0.003) and Ki-67 (r = 0.419, p = 0.020).

Conclusions

3D-APTWI may be used as a supplementary method for patients with contraindications of DCE-MRI. MTRasym can imply the proliferation activities of early-stage BC.

Relevance statement

3D-APTWI can be an alternative diagnostic method for patients with early-stage BC who are not suitable for contrast injection.

Key points

• 3D-APTWI reflects the changes in the microenvironment of early-stage breast cancer.

• Combined 3D-APTWI is superior to DCE-MRI alone for early-stage breast cancer diagnosis.

• 3D-APTWI improves the diagnostic accuracy of early-stage breast cancer.

Graphical Abstract

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Radiology Experimental
European Radiology Experimental Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
6.70
自引率
2.60%
发文量
56
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信